StockClub

AMRX

AMRXAmneal Pharmaceuticals, Inc.$ --
Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc.

AMRX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -100.0%
Operating Income
0M USD
YoY -100.0%
Net Income
-16M USD
YoY -229.1%
EPS
0.27$
YoY +588.8%

Revenue

$0
FY2024 Q2$1.4B
$1.4B
Q2
FY2024 Q3$2.1B
$2.1B
Q3
FY2024 Q4$2.8B
$2.8B
Q4
FY2025 Q1$695.4M
$695.4M
Q1
FY2025 Q2$1.4B
$1.4B
Q2
FY2025 Q3$2.2B
$2.2B
Q3
FY2025 Q4$3B
$3B
Q4
FY2026 Q1$0
$0
Q1
Actual
$-695.4M (-100.0%)

Net Income

$-15.7M
FY2024 Q2$-85.6M
$-85.6M
Q2
FY2024 Q3$-85.8M
$-85.8M
Q3
FY2024 Q4$-116.9M
$-116.9M
Q4
FY2025 Q1$12.2M
$12.2M
Q1
FY2025 Q2$34.6M
$34.6M
Q2
FY2025 Q3$37M
$37M
Q3
FY2025 Q4$72.1M
$72.1M
Q4
FY2026 Q1$-15.7M
$-15.7M
Q1
Actual
$-27.9M (-229.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$2B
Est:$2B
FY2020BEAT
$2B
FY2021BEAT
Actual:$2.1B
Est:$2.1B
FY2021BEAT
$2.1B
FY2022BEAT
Actual:$2.2B
Est:$2.2B
FY2022BEAT
$2.2B
FY2023MISS
Actual:$2.4B
Est:$2.6B
FY2023MISS
$2.4B
FY2024BEAT
Actual:$2.8B
Est:$2.8B
FY2024BEAT
$2.8B
FY2025BEAT
Actual:$3B
Est:$3B
FY2025BEAT
$3B

Analyst Estimates